Data as of Apr 17
| +0.11 / +0.23%|
The 4 analysts offering 12-month price forecasts for ArthroCare Corp have a median target of 48.25, with a high estimate of 55.00 and a low estimate of 47.00. The median estimate represents a -0.74% decrease from the last price of 48.61.
The current consensus among 6 polled investment analysts is to Hold stock in ArthroCare Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.